Lv41
610 积分 2023-06-30 加入
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure
12天前
已完结
Futibatinib (Lytgobi): A Selective Irreversible FGFR1–4 Inhibitor
12天前
已关闭
A local–global principle for nonequilibrium steady states
1个月前
已完结
Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation
1个月前
已完结
Direct conformational sampling from peptide energy landscapes through hypernetwork-conditioned diffusion
1个月前
已完结
Data as the next challenge in atomistic machine learning
1个月前
已完结
Enhanced Sampling of Biomolecular Slow Conformational Transitions Using Adaptive Sampling and Machine Learning
2个月前
已完结
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach
2个月前
已完结
Caught between a ROCK and a hard place: current challenges in structure-based drug design
2个月前
已完结
Steered Molecular Dynamics
3个月前
已完结
皖公网安备34019202002308
